⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1672191 | 0.64 | — | — | |
| SCHEMBL10719628 | 0.64 | — | — | |
| SCHEMBL1411637 | 0.64 | — | — | |
| SCHEMBL11225409 | 0.64 | — | — | |
| SCHEMBL4725492 | 0.64 | — | — | |
| SCHEMBL9207872 | 0.56 | — | — | |
| SCHEMBL132811 | 0.56 | — | — | |
| SCHEMBL453625 | 0.56 | — | — | |
| SCHEMBL79832 | 0.56 | — | — | |
| SCHEMBL1499187 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011055135-A2 | DANCE SHOE AND METHOD OF MANUFACTURE THEREOF | A E STRUTHERS LIMITED (GB) | 2011-05-12 | — | — | WO | claimed |
| WO-2007106797-A2 | A METHOD OF USE FOR SUBSTITUTED DIPIPERIDINE CCR2 ANTAGONISTS | JANSSEN PHARMACEUTICA, NV (BE) | 2007-09-20 | — | — | WO | claimed |
| US-20070219245-A1 | METHOD OF USE FOR SUBSTITUTED DIPIPERIDINE CCR2 ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-09-20 | — | — | US | claimed |
| EP-1802602-A1 | SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-07-04 | — | — | EP | claimed |
| WO-2006036527-A1 | SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-04-06 | — | — | WO | claimed |
| US-20060069123-A1 | Substituted dipiperidine CCR2 antagonists | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-03-30 | — | — | US | claimed |
| WO-2023163288-A1 | MOBILE TERMINAL PROVIDED WITH DAMPING STRUCTURE | 엘지전자 주식회사 | 2023-08-31 | — | — | WO | disclosed |
| US-20220274970-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2022-09-01 | — | — | US | disclosed |
| CN-114450281-A | Inhibitor compounds | 辛塞拉治疗私人有限公司 | 2022-05-06 | — | — | CN | disclosed |
| US-10577308-B2 | Sodium channel modulators | The Florey Institute (AU) | 2020-03-03 | — | — | US | disclosed |
| US-20180170891-A1 | 4H-Pyran Compounds as Insulin-Regulated Aminopeptidase (IRAP) Inhibitors | MONASH UNIVERSITY (AU) | 2018-06-21 | — | — | US | disclosed |
| US-20180072656-A1 | Sodium Channel Modulators | THE UNIVERSITY OF MELBOURNE (AU) | 2018-03-15 | — | — | US | disclosed |
| US-9828351-B2 | Enzyme interacting agents | MONASH UNIVERSITY (AU) | 2017-11-28 | — | — | US | disclosed |
| EP-0272868-A1 | 1,4-Benzodiazepines with 6-membered heterocyclic rings | MERCK & CO. INC. (US) | 1988-06-29 | — | — | EP | disclosed |
| EP-0248594-A2 | Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same | ORTHO PHARMACEUTICAL CORPORATION (US) | 1987-12-09 | — | — | EP | disclosed |
| EP-0229369-A2 | Cephalosporins, process for their preparation and pharmaceutical compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1987-07-22 | — | — | EP | disclosed |
| EP-0225634-A2 | Antibacterial compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1987-06-16 | — | — | EP | disclosed |
| EP-0149884-A2 | 5-Pyridyl-1,3-thiazole derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-07-31 | — | — | EP | disclosed |
| EP-0048046-B1 | METHOD FOR THE MANUFACTURE OF ETHYLIDENE DIACETATE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-05-09 | — | — | EP | disclosed |
| US-3940441-A | BACTERICIDE | STERLING DRUG INC. (US) | 1976-02-24 | — | — | US | disclosed |